SCHEMBL762142

SCHEMBL762142

c1ccc(-c2c3c(c(-c4ccccn4)c4ccccc24)-c2ccc(-c4c5ccccc5c5c6c(cccc46)-c4ccccc4-5)c4cccc-3c24)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
TGFBR1 P36897 1/20 0.36
KDM4E B2RXH2 7/20 0.36
LMNA P02545 3/20 0.36
CCR1 P32246 3/20 0.36
CCR5 P51681 3/20 0.36
CCR8 P51685 3/20 0.36
HIF1A Q16665 2/20 0.36
POLB P06746 2/20 0.36
CYP1A2 P05177 1/20 0.36
METAP1 P53582 1/20 0.36
BLM P54132 1/20 0.36
DOHH Q9BU89 1/20 0.36
P4HTM Q9NXG6 1/20 0.36
TP53 P04637 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HPGD P15428 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13016380 0.90 KDM4E (0.42) CRHBPCRHR2KEAP1NFE2L2TGFBR1
SCHEMBL762746 0.83 DHODH (0.38) TGFBR1KDM4ELMNACCR1CCR5
SCHEMBL762280 0.82 PDK2 (0.35) CRHBPCRHR2KEAP1NFE2L2TGFBR1
SCHEMBL762129 0.81 BRD4 (0.35) TGFBR1KDM4ELMNACCR1CCR5
SCHEMBL17692139 0.80 KDM4E (0.48) CRHBPCRHR2KEAP1NFE2L2TGFBR1
SCHEMBL132284 0.79 KDM4E (0.52) KDM4ELMNACCR1CCR5CCR8
SCHEMBL13016377 0.79 PRKDC (0.39) CRHBPCRHR2KEAP1NFE2L2TGFBR1
SCHEMBL12431260 0.78 KDM4E (0.47) TGFBR1KDM4ELMNACCR1CCR5
SCHEMBL12367181 0.78 TGFBR1 (0.38) TGFBR1KDM4ELMNACCR1CCR5
SCHEMBL13085214 0.77 TGFBR1 (0.42) TGFBR1KDM4ELMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138668-B2 Benzo[a]fluoranthene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2012-03-20 US disclosed
US-8138668-B2 Benzo[a]fluoranthene compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2012-03-20 US disclosed
US-20100019661-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-01-28 US disclosed
US-20100019661-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100019661-A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AFF1, AFF2, CYP1A1 CRHBP 4008/4885CRHR2 2530/4885KEAP1 2048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.